Marginal Impact of Tocilizumab Monotherapy on Anti-HLA Alloantibodies in Highly Sensitized Kidney Transplant Candidates

by Mélanie Daligault, MS, Béatrice Bardy, MD, Johan Noble, MD, Anne Bourdin, RA, Dominique Masson, MD, Hamza Naciri Bennani, MD, Mathilde Bugnazet, BSB, Paolo Malvezzi, MD, Lionel Rostaing, MD, PhD, Thomas Jouve, MD, PhD
Published 2021-05-01